financetom
Business
financetom
/
Business
/
Tesla chair sees challenges in getting shareholder vote for Musk's pay package, FT reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tesla chair sees challenges in getting shareholder vote for Musk's pay package, FT reports
May 17, 2024 7:56 AM

May 17 (Reuters) - Tesla's chair of the board

said the company needs to climb "Mount Everest" as it faces

shareholder votes on relocating to Texas and CEO Elon Musk's $56

billion pay deal, the Financial Times reported on Friday.

Robyn Denholm, who has held Tesla's chairperson position

since 2018, also dismissed criticism that she is too close to

Musk, according to the report.

Last month, Denholm asked shareholders to reaffirm their

approval of Musk's record-breaking $56 billion compensation that

was rejected by a Delaware judge in January.

The board is in early days of the campaign and will meet

with shareholders all the way through to the day of the vote,

Denholm told the Financial Times.

The largest pay package in corporate America has no salary

or cash bonus and sets rewards based on Tesla's market value

rising to as much as $650 billion over the next 10 years from

2018.

"Every shareholder that I've ever talked to says that (the

compensation plan) worked, Denholm said, adding that they

appreciate that it drove a lot of shareholder value, according

to the report.

Tesla's board has repeatedly come under fire for its close

ties with the billionaire.

After the original pay package was voided by Judge Kathaleen

McCormick of Delaware's Court of Chancery, Musk sought to move

Tesla's state of incorporation to Texas from Delaware.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lineage Cell Therapeutics' Q3 net loss widens, driven by warrant liabilities
Lineage Cell Therapeutics' Q3 net loss widens, driven by warrant liabilities
Nov 6, 2025
Overview * Lineage Q3 revenue decreased to $3.7 mln from $3.8 mln in 2024 * Net loss for Q3 increased to $29.75 mln, driven by warrant liabilities Outlook * Lineage plans to drive milestone revenue from Roche and Genentech alliance * Lineage aims to capitalize on investments in cell transplant platform Result Drivers * COLLABORATION WITH WDI - Lineage entered...
Antiviral therapeutics developer SIGA Q3 revenue plummets on lower TPOXX deliveries
Antiviral therapeutics developer SIGA Q3 revenue plummets on lower TPOXX deliveries
Nov 6, 2025
Overview * SIGA ( SIGA ) Q3 revenue declines to $2.6 mln vs $10 mln yr ago, posts a net loss compared to a profit last year * Company attributes revenue decline to lower product sales, especially TPOXX deliveries * SIGA ( SIGA ) focuses on securing new procurement contracts for future revenue growth Outlook * SIGA ( SIGA )...
Intellia Q3 net loss narrows
Intellia Q3 net loss narrows
Nov 6, 2025
Overview * Intellia Q3 net loss narrows to $101.3 mln, collaboration revenue rises * FDA places clinical hold on MAGNITUDE trials due to safety concerns * Enrollment completed in Phase 3 HAELO trial, topline data expected mid-2026 Outlook * Company suspends milestone guidance for nex-z pending regulatory alignment * Intellia expects lonvo-z topline data by mid-2026 * Company anticipates U.S....
Connected fitness platform Peloton beats Q1 revenue estimates
Connected fitness platform Peloton beats Q1 revenue estimates
Nov 6, 2025
Overview * Peloton Q1 FY2026 revenue falls 6% yr/yr but beats guidance * Net income rises to $14 mln, up $15 mln yr/yr * Adjusted EBITDA increases 2% yr/yr, $18 mln above guidance Outlook * Peloton expects Q2 revenue between $665 mln and $685 mln * Company projects Q2 gross margin at approximately 49.0% * Peloton forecasts full-year revenue of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved